What does PBSCT stand for?

Peripheral Blood Stem Cell Transplant

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Peripheral Blood Stem Cell Personal Balanced Scorecard (self-coaching method) Polar Bear Software Company Pro Bono Students Canada Public Buildings and Site Commission Peripheral Blood Stem Cell Collection (cancer treatment) Peripheral Blood Stem Cell Harvest Peripheral Blood Stem Cell Rescue Peripheral Blood Stem Cell Separation Peripheral Blood Stem Cell Support		Palm Beach School District (Florida) Parti Bashkim Shoqeror Demokrat (Social Democratic Union of Albania; political party) Particle Board Sawdust Pine Bluff School District (Arkansas) Plum Borough School District (Plum Borough, PA) Private Banking Services Department Lead Selenide Pasted Bottom, Stepped End (paper bag bottom) Pattern Based Systems Engineering People Buy and Sell Everyday (classifieds)

Samples in periodicals archive:

Bone Marrow and Stem Cell Transplants to Treat Lymphoma Bone Marrow Transplants (BMTs) and their cousin the Peripheral Blood Stem Cell Transplant (PBSCT) are moving from the clinical trial area to mainstream treatment for many cancers, including Hodgkin''s Disease and Medium/High grade (aggressive) Non-Hodgkin''s lymphoma.

Transplants- Transplant of Kidney , Stem Cell and Bone Marrow ...

Today, autologous peripheral blood stem cell transplants are used in treatment and in clinical trials involving patients with a variety of diseases, among them breast cancer, myeloma and leukemia.

"Yes" to adult stem cells

Conclusion: Single low-dose pegfilgrastim as part of a mobilization strategy for autologous peripheral blood stem cell transplant is a viable alternative to filgrastim.

Effective CD34+ stem cell mobilization with low-dose pegfilgrastim

In contrast, it typically takes several weeks for these cells to reach normal levels after a standard peripheral blood stem cell transplant.

Xcyte Therapies, Inc., Presents Results of Clinical Trials in Chronic ...

The company is conducting a Phase III trial to demonstrate the CEPRATE SC System's ability to deplete tumor cells from peripheral blood stem cell transplants in patients being treated for multiple myeloma.

Cellpro reports results for third fiscal quarter